A radiological predictor for pneumomediastinum/pneumothorax in COVID-19 ARDS patients

To determine whether Macklin effect (a linear collection of air contiguous to the bronchovascular sheath) on baseline CT imaging is an accurate predictor for subsequent pneumomediastinum (PMD)/pneumothorax (PNX) development in invasively ventilated patients with COVID-19-related acute respiratory di...

Full description

Saved in:
Bibliographic Details
Published inJournal of critical care Vol. 66; pp. 14 - 19
Main Authors Palumbo, Diego, Zangrillo, Alberto, Belletti, Alessandro, Guazzarotti, Giorgia, Calvi, Maria Rosa, Guzzo, Francesca, Pennella, Renato, Monti, Giacomo, Gritti, Chiara, Marmiere, Marilena, Rocchi, Margherita, Colombo, Sergio, Valsecchi, Davide, Scandroglio, Anna Mara, Dagna, Lorenzo, Rovere-Querini, Patrizia, Tresoldi, Moreno, Landoni, Giovanni, De Cobelli, Francesco, Faustini, Carolina, Maimeri, Nicolò, Lembo, Rosalba, Di Lucca, Giuseppe, Scotti, Raffaella, Lavorato, Maria Vittoria, Tomellieri, Alessandro, Campochiaro, Corrado, Darvizeh, Fatemeh, Calabrese, Francesca, Mapelli, Roberto, Pasculli, Nicola, Borghi, Giovanni, Cipriani, Antonella, Calabrò, Maria Grazia, Crivellari, Martina, Franco, Annalisa, Pieri, Marina, Fominskiy, Evgeny V., Franchini, Stefano, Dell'Acqua, Antonio, Marinosci, Alessandro, Vitali, Giordano, Compagnone, Nicola
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.12.2021
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:To determine whether Macklin effect (a linear collection of air contiguous to the bronchovascular sheath) on baseline CT imaging is an accurate predictor for subsequent pneumomediastinum (PMD)/pneumothorax (PNX) development in invasively ventilated patients with COVID-19-related acute respiratory distress syndrome (ARDS). This is an observational, case-control study. From a prospectively acquired database, all consecutive invasively ventilated COVID-19 ARDS patients who underwent at least one baseline chest CT scan during the study time period (February 25th, 2020–December 31st, 2020) were identified; those who had tracheal lesion or already had PMD/PNX at the time of the first available chest imaging were excluded. 37/173 (21.4%) patients enrolled had PMD/PNX; specifically, 20 (11.5%) had PMD, 10 (5.8%) PNX, 7 (4%) both. 33/37 patients with subsequent PMD/PNX had Macklin effect on baseline CT (89.2%, true positives) 8.5 days [range, 1–18] before the first actual radiological evidence of PMD/PNX. Conversely, 6/136 patients without PMD/PNX (4.4%, false positives) demonstrated Macklin effect (p < 0.001). Macklin effect yielded a sensitivity of 89.2% (95% confidence interval [CI]: 74.6–96.9), a specificity of 95.6% (95% CI: 90.6–98.4), a positive predictive value (PV) of 84.5% (95% CI: 71.3–92.3), a negative PV of 97.1% (95% CI: 74.6–96.9) and an accuracy of 94.2% (95% CI: 89.6–97.2) in predicting PMD/PNX (AUC:0.924). Macklin effect accurately predicts, 8.5 days in advance, PMD/PNX development in COVID-19 ARDS patients. •Macklin effect can be regarded as an early detector of lung frailty.•Macklin effect accurately predicts barotrauma in COVID-19 ARDS patients.•Median delay between Macklin effect first evidence and barotrauma onset was 8.5 days.•Patients with Macklin effect might benefit from ultraprotective ventilation strategy.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
A complete list of COVID-BioB Study Group investigators is presented below and in the Supplementary Appendix.
ISSN:0883-9441
1557-8615
DOI:10.1016/j.jcrc.2021.07.022